The new erection-enhancing condom CSD500—known as "the Viagra condom" awaits regulatory approval in Europe and could be on the shelves of European pharmacies and stores by the end of the year, reports The Wall Street Journal.
CSD500 contains a blood flow-boosting gel that helps men maintain a firmer erection for a longer time period as the agent is absorbed through the skin. The condom will be marketed toward men who have difficulty maintaining an erection while wearing a condom.
The technology is licensed to SSL International, the owner of Durex, the world’s leading condom brand, reports Portfolio.com. No word on when the condoms would be available stateside—but Durex is reportedly interested in marketing them in the U.S., the world's largest condom market. "It’s not clear whether the manufacturer plans to apply to the FDA to market the product here, but the agency would certainly require more data reflecting U.S. patients," adds WSJ.
Thoughts? Good idea or marketing gimmick?